Kathleen Mays-Wilson

Deferoxamine mesylate in patients with intracerebral haemorrhage (i-DEF): a multicentre, randomised, placebo-controlled, double-blind phase 2 trial

Magdy Selim, Lydia D. Foster, Claudia S. Moy et al. · The Lancet Neurology · 2019 · 239 citations · Full text

Thrombosis, Reperfusion Injury, Deferoxamine Mesylate +11

Safety and Outcomes in Stroke Mimics after Intravenous Tissue Plasminogen Activator Administration: A Single-center Experience

Christopher Lewandowski, Kathleen Mays-Wilson, Joseph Miller et al. · Journal of Stroke and Cerebrovascular Diseases · 2014 · 30 citations

Cerebrovascular Disease, Thrombosis, Stroke +16

Clevidipine for acute hypertension in patients with subarachnoid hemorrhage: a pilot study

Panayiotis N. Varelas, Tamer Abdelhak, Jesse J. Corry et al. · International Journal of Neuroscience · 2013 · 22 citations